Emylcamate

This classification denotes an anxiolytic with the molecular formula C7H15NO2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier KCJ747D3R4, chemically known as 3-pentanol, 3-methyl-, carbamate (8ci)(9ci) but generally known as emylcamate, which bears US NIH Compound Identifier 6526. European Medicines Agency schedules Emylcamate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06512MIG. The term EMYLCAMATE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 16, No. 3 1962, List 4). World Health Organization schedules emylcamate in its Anatomical Therapeutic Chemical (ATC) Classification. EMYLCAMATE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule emylcamate under HS 29241900 and SITC 51471. As of Q4 2014, EMYLCAMATE remains the US FDA Preferred Term for this commodity. Emylcamate bears US NLM identifiers UMLS ID C0175159 and NCI Concept Code C76506. SMILES: O(C(CC)(CC)C)C(=O)N.